Advancing Transplantation Outcomes in Children

NCT06055608 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

200

Enrollment

NIH

Sponsor class

Conditions

Kidney Transplant

Interventions

DRUG: Sirolimus
BIOLOGICAL: Belatacept
DRUG: Mycophenolate Mofetil
DRUG: Tacrolimus (Group1)
DRUG: Anti-Thymocyte Globulin (ATG)
DRUG: Tacrolimus (Group 2)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)